Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Transferrin is a glycoprotein that plays a central role in iron metabolism by binding and transporting iron in the bloodstream to various tissues, including the bone marrow where red blood cells are produced. The use of transferrin in the context of anemia is primarily scientifically validated, particularly in cases where anemia is due to disorders of iron transport or chronic diseases that disrupt normal iron homeostasis. Several studies have demonstrated that transferrin supplementation or transferrin-based therapies can improve erythropoiesis (the process of producing red blood cells) in both animal models and human clinical settings, especially for patients with anemia of chronic disease or congenital disorders such as atransferrinemia (a rare genetic disorder characterized by the absence of transferrin). Transferrin therapy is not typically used for common forms of anemia like iron deficiency anemia, where oral or intravenous iron supplementation is the mainstay, but it can be beneficial in specific clinical scenarios where iron is present in the body but cannot be effectively delivered to the bone marrow due to low transferrin levels. Recombinant human transferrin and transferrin mimetics are being explored in clinical trials to address these niche indications. Overall, the scientific foundation for transferrin use in certain types of anemia is robust, though its application is limited to well-defined patient populations rather than general anemia cases.

More about Transferrin
More about Anemia

Other ingredients used for Anemia

Other health conditions supported by Transferrin

Products containing Transferrin